LENZ LENZ THERAPEUTICS INC Product Launches 8-K Filing 2024 - FDA Application LENZ Therapeutics submitted a New Drug Application to the FDA for its drug LNZ100 on August 12, 2024.Get access to all SEC 8-K filings of the LENZ THERAPEUTICS INC